Literature DB >> 14992581

Pathway for polyarginine entry into mammalian cells.

Stephen M Fuchs1, Ronald T Raines.   

Abstract

Cationic peptides known as protein transduction domains (PTDs) provide a means to deliver molecules into mammalian cells. Here, nonaarginine (R(9)), the most efficacious of known PTDs, is used to elucidate the pathway for PTD internalization. Although R(9) is found in the cytosol as well as the nucleolus when cells are fixed, this peptide is observed only in the endocytic vesicles of live cells. Colocalization studies with vesicular markers confirm that PTDs are internalized by endocytosis rather than by crossing the plasma membrane. The inability of R(9) to enter living cells deficient in heparan sulfate (HS) suggests that binding to HS is necessary for PTD internalization. This finding is consistent with the high affinity of R(9) for heparin (K(d) = 109 nM). Finally, R(9) is shown to promote the leakage of liposomes but only at high peptide:lipid ratios. These and other data indicate that the PTD-mediated delivery of molecules into live mammalian cells involves (1) binding to cell surface HS, (2) uptake by endocytosis, (3) release upon HS degradation, and (4) leakage from endocytic vesicles.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14992581      PMCID: PMC2819928          DOI: 10.1021/bi035933x

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  57 in total

Review 1.  Heparan sulfate proteoglycans: intricate molecules with intriguing functions.

Authors:  R V Iozzo
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

2.  Ribonuclease A.

Authors:  Ronald T. Raines
Journal:  Chem Rev       Date:  1998-05-07       Impact factor: 60.622

Review 3.  Protein transduction domains: are they delivering?

Authors:  Isabelle Green; Richard Christison; Catherine J Voyce; Ken R Bundell; Mark A Lindsay
Journal:  Trends Pharmacol Sci       Date:  2003-05       Impact factor: 14.819

4.  Genetic engineering of proteins with cell membrane permeability.

Authors:  M Rojas; J P Donahue; Z Tan; Y Z Lin
Journal:  Nat Biotechnol       Date:  1998-04       Impact factor: 54.908

Review 5.  Follistatin and its role as an activin-binding protein.

Authors:  H Sugino; K Sugino; O Hashimoto; H Shoji; T Nakamura
Journal:  J Med Invest       Date:  1997-08

6.  Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein.

Authors:  M Green; P M Loewenstein
Journal:  Cell       Date:  1988-12-23       Impact factor: 41.582

7.  Oligocarbamate molecular transporters: design, synthesis, and biological evaluation of a new class of transporters for drug delivery.

Authors:  Paul A Wender; Jonathan B Rothbard; Theodore C Jessop; Erik L Kreider; Bryan L Wylie
Journal:  J Am Chem Soc       Date:  2002-11-13       Impact factor: 15.419

8.  Molecular vehicles for targeted drug delivery.

Authors:  Marina V Backer; Renee Aloise; Kristen Przekop; Konstantin Stoletov; Joseph M Backer
Journal:  Bioconjug Chem       Date:  2002 May-Jun       Impact factor: 4.774

Review 9.  Cellular uptake and intracellular fate of antisense oligonucleotides.

Authors:  Alain R Thierry; Eric Vives; Jean-Philippe Richard; Paul Prevot; Camille Martinand-Mari; Ian Robbins; Bernard Lebleu
Journal:  Curr Opin Mol Ther       Date:  2003-04

Review 10.  Protein transduction technology offers novel therapeutic approach for brain ischemia.

Authors:  Catherine Denicourt; Steven F Dowdy
Journal:  Trends Pharmacol Sci       Date:  2003-05       Impact factor: 14.819

View more
  94 in total

1.  Translocation of HIV TAT peptide and analogues induced by multiplexed membrane and cytoskeletal interactions.

Authors:  Abhijit Mishra; Ghee Hwee Lai; Nathan W Schmidt; Victor Z Sun; April R Rodriguez; Rong Tong; Li Tang; Jianjun Cheng; Timothy J Deming; Daniel T Kamei; Gerard C L Wong
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-03       Impact factor: 11.205

2.  Characterization of the cell-penetrating properties of the Epstein-Barr virus ZEBRA trans-activator.

Authors:  Romy Rothe; Lavinia Liguori; Ana Villegas-Mendez; Bruno Marques; Didier Grunwald; Emmanuel Drouet; Jean-Luc Lenormand
Journal:  J Biol Chem       Date:  2010-04-09       Impact factor: 5.157

Review 3.  Internalization of cationic peptides: the road less (or more?) traveled.

Authors:  S M Fuchs; R T Raines
Journal:  Cell Mol Life Sci       Date:  2006-08       Impact factor: 9.261

Review 4.  The taming of the cell penetrating domain of the HIV Tat: myths and realities.

Authors:  Ashok Chauhan; Akshay Tikoo; Arvinder K Kapur; Mahavir Singh
Journal:  J Control Release       Date:  2006-11-17       Impact factor: 9.776

5.  Multilayered films fabricated from an oligoarginine-conjugated protein promote efficient surface-mediated protein transduction.

Authors:  Christopher M Jewell; Stephen M Fuchs; Ryan M Flessner; Ronald T Raines; David M Lynn
Journal:  Biomacromolecules       Date:  2007-02-02       Impact factor: 6.988

Review 6.  Cell penetrating peptides: intracellular pathways and pharmaceutical perspectives.

Authors:  Leena N Patel; Jennica L Zaro; Wei-Chiang Shen
Journal:  Pharm Res       Date:  2007-04-19       Impact factor: 4.200

7.  Cellular binding, motion, and internalization of synthetic gene delivery polymers.

Authors:  Gaelen T Hess; William H Humphries; Nicole C Fay; Christine K Payne
Journal:  Biochim Biophys Acta       Date:  2007-08-07

8.  Molecular umbrella transport: exceptions to the classic size/lipophilicity rule.

Authors:  Mohamed Mehiri; Wen-Hua Chen; Vaclav Janout; Steven L Regen
Journal:  J Am Chem Soc       Date:  2009-02-04       Impact factor: 15.419

9.  TAT peptide and its conjugates: proteolytic stability.

Authors:  Jacob Grunwald; Tomas Rejtar; Rupa Sawant; Zhouxi Wang; Vladimir P Torchilin
Journal:  Bioconjug Chem       Date:  2009-07-14       Impact factor: 4.774

10.  A new approach to glycan targeting: enzyme inhibition by oligosaccharide metalloshielding.

Authors:  John B Mangrum; Brigitte J Engelmann; Erica J Peterson; John J Ryan; Susan J Berners-Price; Nicholas P Farrell
Journal:  Chem Commun (Camb)       Date:  2014-04-21       Impact factor: 6.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.